Prof. Johann Bauer: Clinical Trials

1 trial sponsored by Prof. Johann Bauer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Prof. Johann Bauer: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rigosertib for RDEB-SCC
Rigosertib Oral Capsules / Rigosertib Intravenous - Epidermolysis Bullosa Dystrophica, Squamous Cell Carcinoma
Phase 1 / Phase 2CompletedProf. Johann Bauer22021-04-122026-02-24

Conditions studied

Carcinoma, Squamous Cell (1)  ·  Epidermolysis Bullosa Dystrophica (1)

Interventions

ON 01910 (1)

Countries

Austria (1)

Top investigators

Johann W Bauer, Prof., MD (1)